Advantages and Limitations of Animal Schizophrenia Models

被引:50
|
作者
Bialon, Magdalena [1 ]
Wasik, Agnieszka [1 ]
机构
[1] Polish Acad Sci, Maj Inst Pharmacol, Dept Neurochem, PL-31343 Krakow, Poland
关键词
animal models of schizophrenia; amphetamine; phencyclidine (PCP); ketamine; dizocilpine (MK-801); neurotrophic factor neuregulin 1 (NRG1); disrupted-in-schizophrenia 1 (DISC-1) gene; neonatal ventral hippocampal lesion (NVHL); maternal immune activation (MIA); methylazoxymethanol acetate (MAM); MATERNAL IMMUNE ACTIVATION; MEDIAL PREFRONTAL CORTEX; NEURODEVELOPMENTAL RAT MODEL; DISRUPTS PREPULSE INHIBITION; NEONATAL EXCITOTOXIC LESIONS; BDNF MESSENGER-RNA; MOUSE MODEL; NUCLEUS-ACCUMBENS; WORKING-MEMORY; COGNITIVE IMPAIRMENT;
D O I
10.3390/ijms23115968
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mental illness modeling is still a major challenge for scientists. Animal models of schizophrenia are essential to gain a better understanding of the disease etiopathology and mechanism of action of currently used antipsychotic drugs and help in the search for new and more effective therapies. We can distinguish among pharmacological, genetic, and neurodevelopmental models offering various neuroanatomical disorders and a different spectrum of symptoms of schizophrenia. Modeling schizophrenia is based on inducing damage or changes in the activity of relevant regions in the rodent brain (mainly the prefrontal cortex and hippocampus). Such artificially induced dysfunctions approximately correspond to the lesions found in patients with schizophrenia. However, notably, animal models of mental illness have numerous limitations and never fully reflect the disease state observed in humans.
引用
收藏
页数:32
相关论文
共 50 条
  • [1] Genetic animal models for schizophrenia: advantages and limitations of genetic manipulation in drosophila, zebrafish, rodents, and primates
    Sawa, Akira
    [J]. GENETIC MODELS OF SCHIZOPHRENIA, 2009, 179 : 3 - 6
  • [2] Advantages and limitations of experimental animal models for the study of infectious diseases
    Cardona, PJ
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2003, 21 (07): : 327 - 328
  • [3] ADVANTAGES AND LIMITATIONS OF ANIMAL-MODELS IN EVALUATION OF ANTIVIRAL SUBSTANCES
    GLASGOW, LA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1976, 133 : A73 - A78
  • [4] Animal models relevant to schizophrenia and autism: Validity and limitations
    Tordjman, Sylvie
    Drapier, Dominique
    Bonnot, Olivier
    Graignic, Rozenn
    Fortes, Sylvia
    Cohen, David
    Millet, Bruno
    Laurent, Claudine
    Roubertoux, Pierre L.
    [J]. BEHAVIOR GENETICS, 2007, 37 (01) : 61 - 78
  • [5] Limitations and Value of Animal Models of Relevance to the Schizophrenia Prodrome
    Yung, Alison R.
    [J]. BIOLOGICAL PSYCHIATRY: GLOBAL OPEN SCIENCE, 2023, 3 (01): : 3 - 5
  • [6] Animal Models Relevant to Schizophrenia and Autism: Validity and Limitations
    Sylvie Tordjman
    Dominique Drapier
    Olivier Bonnot
    Rozenn Graignic
    Sylvia Fortes
    David Cohen
    Bruno Millet
    Claudine Laurent
    Pierre L. Roubertoux
    [J]. Behavior Genetics, 2007, 37 : 61 - 78
  • [7] Neurophotonic methods in approach to in vivo animal epileptic models: Advantages and limitations
    Tsytsarev, Vassiliy
    Sopova, Julia V.
    Leonova, Elena I.
    Inyushin, Mikhail
    Markina, Alisa A.
    Chirinskaite, Angelina V.
    Volnova, Anna B.
    [J]. EPILEPSIA, 2024, 65 (03) : 600 - 614
  • [8] Animal models for type 1 and type 2 diabetes: advantages and limitations
    Singh, Raj
    Gholipourmalekabadi, Mazaher
    Shafikhani, Sasha H.
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [9] Advantages and limitations of nonhuman primates as animal models in genetic research on complex diseases
    VandeBerg, JL
    WilliamsBlangero, S
    [J]. JOURNAL OF MEDICAL PRIMATOLOGY, 1997, 26 (03) : 113 - 119
  • [10] Animal models in the genomic era: possibilities and limitations with special emphasis on schizophrenia
    Ellenbroek, BA
    [J]. BEHAVIOURAL PHARMACOLOGY, 2003, 14 (5-6): : 409 - 417